Endpoints News 5 may 2026 Second life for gene therapy; Takeda Phase 2/3 win; UK cancer biotech's $83M
BioNTech 5 may 2026 BioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback - Fierce Pharma
Eli Lilly 5 may 2026 AI is saving pharma billions in manufacturing and back-office work, just not in the lab - the-decoder.com
BioNTech 5 may 2026 BioNTech to cut fifth of workforce as it winds down Covid vaccine production - Financial Times
FierceBiotech 5 may 2026 Madrigal continues MASH deal spree with $1B biobucks license for Arrowhead asset rejected by J&J
Endpoints News 5 may 2026 Microbiome startup raises $48M for immunotherapy and malnutrition treatments
BioNTech 5 may 2026 BioNTech moves to close multiple manufacturing plants, affecting 1,860 jobs - BioSpace
Novartis 5 may 2026 Biopharma bites: FDA withholds vaccine data, plus staffing cuts for Novartis, Gilead - FirstWord Pharma
FierceBiotech 5 may 2026 Pfizer’s $2.3B Trillium bet ends in failure as remaining CD47 blocker scrapped along with T-cell engager